Table 6.
Clinical data related to 30-day prognosis of 561 patients with sICH.
| Total | Slight disability | Moderate disability | Moderately severe disability | Severe disability | Dead | χ2/F | P | ||
| Total | n (%) | 561 | 22 (3.92) | 97 (17.29) | 219 (39.04) | 120 (21.39) | 103 (18.36) | ||
| Gender | 11.558∗ | .021 | |||||||
| Male | 360 (64.17) | 19 (5.28) | 58 (16.11) | 128 (35.56) | 82 (22.78) | 73 (20.28) | |||
| Female | 201 (35.83) | 3 (1.49) | 39 (19.40) | 91 (45.27) | 38 (18.91) | 30 (14.93) | |||
| Age (yr) | 63.2 ± 12.4 | 61.8 ± 15.4 | 62.7 ± 12.8 | 62.4 ± 11.9 | 62.4 ± 11.3 | 66.6 ± 13.2 | 2.440† | .046 | |
| Onset season | 15.716∗ | .205 | |||||||
| Spring | 154 (27.45) | 6 (3.90) | 19 (12.34) | 66 (42.86) | 31 (20.13) | 32 (20.78) | |||
| Summer | 111 (19.79) | 4 (3.60) | 23 (20.72) | 38 (34.23) | 22 (19.82) | 24 (21.62) | |||
| Autumn | 133 (23.71) | 4 (3.01) | 31 (23.31) | 50 (37.59) | 34 (25.56) | 14 (10.53) | |||
| Winter | 163 (29.06) | 8 (4.91) | 24 (14.72) | 65 (39.88) | 33 (20.25) | 33 (20.25) | |||
| Time to hospital encounter (h) | 4.55 ± 5.25 | 4.75 ± 5.06 | 5.13 ± 6.17 | 4.57 ± 5.27 | 4.39 ± 4.87 | 4.09 ± 4.73 | 0.536† | .709 | |
| Hypertension | 8.690∗ | .069 | |||||||
| No | 297 (52.94) | 15 (5.05) | 52 (17.51) | 116 (39.06) | 52 (17.51) | 62 (20.88) | |||
| Yes | 264 (47.06) | 7 (2.65) | 45 (17.05) | 103 (39.02) | 68 (25.76) | 41 (15.53) | |||
| Duration (yr) | 6.5 ± 5.1 | 4.6 ± 2.2 | 5.9 ± 4.1 | 6.7 ± 5.2 | 6.3 ± 4.9 | 7.5 ± 6.5 | 0.871† | .482 | |
| Admission systolic pressure (mm Hg) | 178.0 ± 31.1 | 159.7 ± 30.1 | 174.4 ± 27.6 | 175.7 ± 27.8 | 178.9 ± 33.3 | 188.9 ± 35.1 | 5.947† | <.001 | |
| Admission diastolic pressure (mm Hg) | 98.1 ± 18.2 | 91.9 ± 15.6 | 96.9 ± 16.8 | 97.3 ± 17.2 | 98.5 ± 19.9 | 101.8 ± 19.8 | 1.885† | .112 | |
| Diabetes | 6.647∗ | .156 | |||||||
| No | 534 (95.19) | 20 (3.75) | 92 (17.23) | 211 (39.51) | 110 (20.60) | 101 (18.91) | |||
| Yes | 27 (4.81) | 2 (7.41) | 5 (18.52) | 8 (29.63) | 10 (37.04) | 2 (7.41) | |||
| Duration (yr) | 7.7 ± 5.8 | 12.0 ± 11.3 | 11.2 ± 8.5 | 7.5 ± 4.1 | 5.3 ± 4.4 | 7.5 ± 3.5 | 1.191† | .342 | |
| Admission blood glucose (mmol/L) | 7.94 ± 2.81 | 7.12 ± 2.14 | 7.13 ± 2.48 | 7.64 ± 2.59 | 8.23 ± 2.79 | 9.14 ± 3.26 | 8.545† | <.001 | |
| Smoking | 4.949∗ | .293 | |||||||
| No | 353 (62.92) | 10 (2.83) | 57 (16.15) | 146 (41.36) | 76 (21.53) | 64 (18.13) | |||
| Yes | 208 (37.08) | 12 (5.77) | 40 (19.23) | 73 (35.10) | 44 (21.15) | 39 (18.75) | |||
| Duration (yr) | 31.9 ± 12.9 | 35.4 ± 12.2 | 30.8 ± 11.8 | 31.3 ± 13.8 | 31.5 ± 12.9 | 33.4 ± 12.8 | 0.472† | .756 | |
| Daily smoking volume (cigarettes / day) | 15.7 ± 8.4 | 16.7 ± 4.9 | 16.6 ± 7.3 | 14.4 ± 7.3 | 15.3 ± 10.0 | 17.2 ± 10.0 | 0.965† | .428 | |
| Drinking | 1.403∗ | .844 | |||||||
| No | 359 (63.99) | 13 (3.62) | 63 (17.55) | 145 (40.39) | 76 (21.17) | 62 (17.27) | |||
| Yes | 202 (36.01) | 9 (4.46) | 34 (16.83) | 74 (36.63) | 44 (21.78) | 41 (20.30) | |||
| Duration (yr) | 29.7 ± 12.5 | 30.8 ± 11.8 | 31.2 ± 14.4 | 30.4 ± 11.9 | 28.6 ± 13.1 | 27.9 ± 11.8 | 0.488† | .745 | |
| Daily drinking volume (g/d) | 169.5 ± 149.1 | 172.2 ± 61.8 | 138.2 ± 70.8 | 127.0 ± 99.0 | 126.7 ± 106.7 | 169.5 ± 149.1 | 1.408† | .233 | |
| Stroke | 0.301∗ | .990 | |||||||
| Yes | 61 (10.87) | 3 (4.92) | 10 (16.39) | 23 (37.70) | 13 (21.31) | 12 (19.67) | |||
| No | 500 (89.13) | 19 (3.80) | 87 (17.40) | 196 (39.20) | 107 (21.40) | 91 (18.20) | |||
| Oral anticoagulant and/or antiplatelet drugs | 6.532∗ | .163 | |||||||
| Yes | 9 (1.60) | 5 (55.56) | 4 (44.44) | ||||||
| No | 552 (98.40) | 22 (3.99) | 97 (17.57) | 214 (38.77) | 116 (21.01) | 103 (18.66) | |||
| BMI | 22.83 ± 3.30 | 22.08 ± 2.57 | 23.04 ± 3.66 | 23.14 ± 3.16 | 22.85 ± 3.26 | 22.13 ± 3.34 | 2.014† | .091 | |
| Location of bleeding | 57.195∗ | .171 | |||||||
| Basal nucleus | 277 (49.38) | 9 (3.25) | 44 (15.88) | 113 (40.79) | 70 (25.27) | 41 (14.80) | |||
| Thalamus | 86 (15.33) | 1 (1.16) | 21 (24.42) | 32 (37.21) | 16 (18.60) | 16 (18.60) | |||
| Brain stem | 47 (8.38) | 2 (4.26) | 4 (8.51) | 14 (29.79) | 9 (19.15) | 18 (38.30) | |||
| Cerebellum | 38 (6.78) | 2 (5.26) | 10 (26.32) | 18 (47.37) | 3 (7.89) | 5 (13.16) | |||
| Mixed (2 or more than 2 cerebral lobes hemorrhage) | 32 (5.70) | 1 (3.13) | 7 (21.88) | 12 (37.50) | 5 (15.63) | 7 (21.88) | |||
| Multiple sites (bleeding in 2 or more sites) | 30 (5.35) | 2 (6.67) | 5 (16.67) | 8 (26.67) | 6 (20.00) | 9 (30.00) | |||
| Primary ventricle | 15 (2.67) | 3 (20.20) | 2 (13.33) | 4 (26.67) | 4 (26.67) | 2 (13.33) | |||
| Temporal lobe | 10 (1.78) | 1 (10.00) | 2 (20.00) | 4 (40.00) | 1 (10.00) | 2 (20.00) | |||
| Parietal lobe | 10 (1.78) | 1 (10.00) | 5 (50.00) | 3 (30.00) | 1 (10.00) | ||||
| Frontal lobe | 6 (1.07) | 1 (16.67) | 3 (50.00) | 1 (16.67) | 1 (16.67) | ||||
| Putamen | 5 (0.89) | 1 (20.00) | 2 (40.00) | 1 (20.00) | 1 (20.00) | ||||
| Occipital lobe | 4 (0.71) | 3 (75.00) | 1 (25.00) | ||||||
| Caudate nucleus | 1 (0.18) | 1 | |||||||
| Admission GCS (score) | 9.1 ± 2.7 | 12.7 ± 0.8 | 12.2 ± 0.9 | 9.7 ± 1.9 | 7.7 ± 1.3 | 5.7 ± 1.9 | 265.052† | <.001 | |
| Degree of disturbance of consciousness on admission | 570.254∗ | <.001 | |||||||
| Mild | 115 (20.50) | 22 (19.13) | 80 (69.57) | 13 (11.30) | |||||
| Moderate | 224 (39.93) | 17 (7.59) | 156 (69.64) | 42 (18.75) | 9 (4.02) | ||||
| Severe | 222 (39.57) | 50 (22.52) | 78 (35.14) | 94 (42.34) |